Brief: Heat Biologics Announces FDA Clearance Of Investigational New Drug Application For PTX-35
08/06/2020 12:49
June 8 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS - ANNOUNCES FDA CLEARANCE OF
INVESTIGATIONAL NEW
DRUG APPLICATION FOR PTX-35
* HEAT BIOLOGICS - CO'S PELICAN THERAPEUTICS UNIT HAS
NEAR-TERM
PLANS TO INITIATE ITS PHASE 1 CLINICAL TRIAL IN PATIENTS WITH
SOLID TUMORS
Source text: (https://bit.ly/3dKPHue)
Further company coverage: HTBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company